Wegovy Lowers Heart Attack, Stroke Risk by 20%

A new study from Novo Nordisk found the anti-obesity drug Wegovy reduced the risk of heart attack, stroke and heart-related death by 20% in people taking the drug compared to people taking a placebo.

August 10, 2023 Today's top story Wegovy Lowers Heart Attack, Stroke Risk by 20% A new study from Novo Nordisk found the anti-obesity drug Wegovy reduced the risk of heart attack, stroke and heart-related death by 20% in people taking the drug compared to people taking a placebo. Read on       Long-Term Use of Acid Reflux Drugs May Increase Your Risk of Dementia Read ON   Walking Just 4,000 Steps a Day Can Help You Live Longer Read ON   Cognitive Behavioral Therapy May Help Disordered Eating After Bariatric Surgery Read ON   More top Reads       Advertisement Start a custom weight loss program Noom helps you adopt healthy habits so you can lose weight and keep it off. GET STARTED

View in browser Did a friend send you this email? Subscribe here. To see all newsletters, click here. Privacy  |  Unsubscribe Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health. © 2023 Healthline Media LLC 275 7th Ave., 24th Floor New York, NY 10001